| Analysis | Metabolite Name | Measured Value | Units | Group | TIMEPOINT |
|---|---|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | hippurate | 0.1306 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.1308 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.1696 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.2520 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.2528 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.2549 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.2624 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.2656 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.2919 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.3228 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.3244 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.3250 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.3308 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.3383 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.3410 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.3720 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.3748 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.3826 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.4076 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.4076 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.4236 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.4555 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.4561 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.4760 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.4868 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.4927 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.4965 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.5014 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.5020 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.5203 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.5287 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.5387 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.5507 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.5631 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.5636 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.5714 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.5738 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.5768 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.5811 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.5812 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.5886 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.5995 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.6032 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.6085 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.6151 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.6172 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.6173 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.6260 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.6362 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.6428 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.6685 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.6722 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.6881 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.7035 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.7037 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.7051 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.7140 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.7155 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.7227 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.7232 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.7243 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.7256 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.7299 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.7341 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.7413 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.7535 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.7784 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.7915 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.8039 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.8112 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.8189 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.8206 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.8314 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.8336 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.8394 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.8409 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.8484 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.8638 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.8931 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.8948 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.9043 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.9083 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.9133 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.9197 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.9565 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.9644 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.9658 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.9797 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.9873 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.9885 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.9929 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.9961 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 0.9988 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.0000 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.0022 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.0039 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.0085 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.0171 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.0256 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.0298 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.0308 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.0317 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.0352 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.0366 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.0447 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.0664 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.0779 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.0870 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.1061 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.1145 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.1172 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.1199 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.1414 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.1448 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.1450 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.1705 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.1706 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.1958 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.2011 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.2157 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.2163 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.2193 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.2317 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.2470 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.2682 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.2820 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.2947 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.3028 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.3116 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.3121 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.3268 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.3482 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.3597 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.3610 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.3670 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.3719 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.3828 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.3853 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.3918 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.3980 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.4169 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.4210 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.4232 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.4374 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.4378 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.4414 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.4482 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.4588 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.4782 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.4834 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.5032 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.5142 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.5418 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.5819 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.5822 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.5851 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.6091 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.6245 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.6440 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.6590 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.6738 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.6891 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.6896 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.7051 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.7070 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.7578 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.7593 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.7631 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.7644 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.7701 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.7711 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.8294 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.8585 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.8609 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 1.8667 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 2.0127 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 2.0329 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | hippurate | 2.0376 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 2.1119 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 2.2628 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | hippurate | 2.2643 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | hippurate | 2.2658 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | hippurate | 2.2894 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | hippurate | 2.3430 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | hippurate | 2.4198 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | hippurate | 2.4683 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | hippurate | 3.6764 | scaled units | High-Dose | -0.5HR |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|